This is not the old Admedus, selling the DurAVR TAVR would be far easier and less labour intensive than the patches (much more concentrated and we have a walk up start with the Ad Board and connections), I think as the genuine superiority of the product emerges the company may be seriously considering the possibility of “going it alone”,
I think that this narrative is crucial to perpetuate regardless as the competition needs to know we are capable and that we “don’t need” a deal (ie - not reliant on a deal as we once were).
When all is said and done regardless of our intentions I strongly doubt that Edwards, Medtronic or another interested party will let us go alone as they will want to own this tech out right. I have no idea how this will play out but I suspect that within 12 to 24 months of us being listed on the Nasdaq we will be acquired. If we go it alone (even for a short period) then even better.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)